← European Medicine Shortage Tracker · all medicines

Clarithromycinlactobionat shortage — availability across Europe

Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.

MEDICALLY REVIEWED
Dr. Chrysoula I. Liakou MD, PhD
Internal Medicine Specialist
Cancer Immunology Researcher
Reviewed 30 July 2026 · next review due 30 January 2027

Clarithromycinlactobionat currently has availability issues reported in 1 European register: Germany.

Shortage  ATC J01FA09 · also listed as: Clarithromycinlactobionat · data refreshed 10 September 2026

Key facts

As of 10 September 2026, 1 of the 9 tracked registers list current availability issues for Clarithromycinlactobionat, covering 1 affected product presentation. The furthest expected-resolution date currently on file is 2026-09-30; the earliest is 2026-09-30. Registers in Germany indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching. In the WHO ATC classification, Clarithromycinlactobionat is coded J01FA09 — a medicine acting on anti-infectives for systemic use — so clinically related products appear under “Related medicines” below.

WhereStatus & productsSinceExpected end Reason / alternativesSource
🇩🇪 GermanyShortage
Clarithromycin Eberth 500 mg Pulver zur Herstellung einer Infusionslösung
2026-08-122026-09-30Sonstige
Alternatives: N/A
register ↗

Full report history (1 register entry)

Every individual register entry for Clarithromycinlactobionat in the tracked sources, newest first — including resolved and discontinued reports.

Reg.ProductStatusReportedExpected endStated reason
🇩🇪 DEClarithromycin Eberth 500 mg Pulver zur Herstellung einer InfusionslösShortage2026-08-122026-09-30Sonstige

Frequently asked

Is Clarithromycinlactobionat currently in shortage in Europe?

Yes. As of 10 September 2026, availability issues are reported in: Germany. Availability is national — a shortage in one country does not mean it is short everywhere.

When is the Clarithromycinlactobionat shortage expected to end?

Agency prognoses on file range from 2026-09-30 to 2026-09-30. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.

Are there alternatives to Clarithromycinlactobionat?

1 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.

Where does this Clarithromycinlactobionat availability data come from?

Directly from the official medicines-agency register that lists Clarithromycinlactobionat: BfArM (Germany). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.

Related medicines (same ATC class)

Embed this tracker

Pharmacies, patient sites and newsrooms are welcome to embed the live status of Clarithromycinlactobionat — free, with attribution. Copy this snippet:

<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/clarithromycinlactobionat/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Clarithromycinlactobionat availability in Europe"></iframe>
<p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/clarithromycinlactobionat/">Clarithromycinlactobionat shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>
Cite: “Clarithromycinlactobionat: availability status across 1 European registers — European Medicine Shortage Tracker (MobiDoctor), 10 September 2026.” Link this page and the agency record. Statuses come from the linked official registers and can change daily.